Literature DB >> 30463683

Pattern and impact of metastatic cardiophrenic lymph nodes in advanced epithelial ovarian cancer.

Sonia Prader1, Nils Vollmar2, Andreas du Bois3, Florian Heitz1, Stephanie Schneider1, Beyhan Ataseven1, Mareike Bommert1, Kai-Uwe Waltering2, Sebastian Heikaus4, Jens Albrecht Koch2, Pier Francesco Alesina5, Alexander Traut1, Philipp Harter1.   

Abstract

BACKGROUND: Cardiophrenic lymph nodes (CPLN) define FIGO stage IVB disease. We evaluate the pattern of CPLN metastases, their prognostic impact and the potential role of CPLN resection in patients with epithelial ovarian cancer (EOC).
METHODS: Analysis of 595 consecutive patients with EOC treated in the period 01/2011-05/2016. CT scans were re-reviewed by two radiologists. Positive CPLN were defined as ≥5 mm in the short-axis diameter. The role of CPLN resection was evaluated in a case-control matched-pair analysis.
RESULTS: Of 595 patients 458 had FIGO stage IIIB-IV disease. We excluded patients undergoing interval surgery (n = 54), without debulking surgery (n = 32) and without sufficient pre-operative imaging (n = 22), resulting in a study cohort of 350 patients. Of these, 133 (37.9%) had negative CPLN and 217 (62.0%) had radiologically positive CPLN. In patients with postoperative residual tumor, enlarged CPLN had no impact on survival. In patients with complete resection (n = 223), 98 (44.0%) had negative CPLN and a 5-year OS of 69% and a 5-year PFS of 41%; in contrast, in the 125 patients (56.0%) with positive CPLN, 5-year OS was 30% and 5-year PFS was 13%. In 52 patients we resected CPLN. The matched-pair case-control analysis did not demonstrate any significant impact on survival of CPLN resection.
CONCLUSION: CPLN metastases are associated with impaired PFS and OS in patients with macroscopically completely resected tumor. Intraabdominal residual tumor has a greater prognostic impact than positive CPLN. The impact of the resection of CPLN remains unclear.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiophrenic lymph nodes; Lymphadenectomy; Ovarian cancer

Mesh:

Year:  2018        PMID: 30463683     DOI: 10.1016/j.ygyno.2018.11.001

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  4 in total

1.  Minimally Invasive Secondary Cytoreductive Surgery for Superficial Celiac and Cardio-Phrenic Isolated Nodal Recurrence of Ovarian Cancer.

Authors:  M Loverro; R Ergasti; C Conte; V Gallitelli; D Nachira; G Scaglione; A Fagotti; G Scambia; V Gallotta
Journal:  Ann Surg Oncol       Date:  2022-01-08       Impact factor: 5.344

2.  ASO Author Reflections: Minimally Invasive Secondary Cytoreductive Surgery for Ovarian Cancer Lymph Node Recurrence: Shaping Treatment with All Arrows in our Quiver.

Authors:  Matteo Loverro; Raffaella Ergasti; Carmine Conte; Vitalba Gallitelli; Dania Nachira; Giulia Scaglione; Anna Fagotti; Giovanni Scambia; Valerio Gallotta
Journal:  Ann Surg Oncol       Date:  2022-01-22       Impact factor: 5.344

3.  Postoperative chest liver herniation after cardiophrenic lymph node resection by a transdiaphragmatic approach following primary cytoreductive surgery for advanced endometrioid ovarian cancer: A case report.

Authors:  Hélène Leray; Laurent Brouchet; Yann Tanguy Le Gac; Sihem Bouharaoua; Philippe Otal; Gwenaël Ferron; Erwan Gabiache; Martina Aida Angeles; Carlos Martínez-Gómez; Alejandra Martinez
Journal:  Gynecol Oncol Rep       Date:  2021-02-13

4.  The role of computed tomography in the assessment of tumour extent and the risk of residual disease after upfront surgery in advanced ovarian cancer (AOC).

Authors:  Mihaela Asp; Susanne Malander; Nils-Olof Wallengren; Sonja Pudaric; Johan Bengtsson; Hanna Sartor; Päivi Kannisto
Journal:  Arch Gynecol Obstet       Date:  2022-03-02       Impact factor: 2.493

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.